Creative Medical Technology (CELZ) Competitors $2.79 +0.05 (+1.82%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELZ vs. MIRA, TPST, FBLG, ALXO, QTTB, CVKD, TENX, PULM, NNVC, and BCABShould you be buying Creative Medical Technology stock or one of its competitors? The main competitors of Creative Medical Technology include MIRA Pharmaceuticals (MIRA), Tempest Therapeutics (TPST), FibroBiologics (FBLG), ALX Oncology (ALXO), Q32 Bio (QTTB), Cadrenal Therapeutics (CVKD), Tenax Therapeutics (TENX), Pulmatrix (PULM), NanoViricides (NNVC), and BioAtla (BCAB). These companies are all part of the "pharmaceutical products" industry. Creative Medical Technology vs. Its Competitors MIRA Pharmaceuticals Tempest Therapeutics FibroBiologics ALX Oncology Q32 Bio Cadrenal Therapeutics Tenax Therapeutics Pulmatrix NanoViricides BioAtla MIRA Pharmaceuticals (NASDAQ:MIRA) and Creative Medical Technology (NASDAQ:CELZ) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment. Do insiders and institutionals believe in MIRA or CELZ? 35.2% of MIRA Pharmaceuticals shares are held by institutional investors. Comparatively, 1.4% of Creative Medical Technology shares are held by institutional investors. 6.7% of MIRA Pharmaceuticals shares are held by company insiders. Comparatively, 1.8% of Creative Medical Technology shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is MIRA or CELZ more profitable? Creative Medical Technology's return on equity of -85.26% beat MIRA Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets MIRA PharmaceuticalsN/A -341.08% -272.93% Creative Medical Technology N/A -85.26%-81.49% Which has more risk and volatility, MIRA or CELZ? MIRA Pharmaceuticals has a beta of 1.72, indicating that its share price is 72% more volatile than the S&P 500. Comparatively, Creative Medical Technology has a beta of 2.04, indicating that its share price is 104% more volatile than the S&P 500. Does the media prefer MIRA or CELZ? In the previous week, Creative Medical Technology had 3 more articles in the media than MIRA Pharmaceuticals. MarketBeat recorded 3 mentions for Creative Medical Technology and 0 mentions for MIRA Pharmaceuticals. Creative Medical Technology's average media sentiment score of 0.49 beat MIRA Pharmaceuticals' score of 0.00 indicating that Creative Medical Technology is being referred to more favorably in the news media. Company Overall Sentiment MIRA Pharmaceuticals Neutral Creative Medical Technology Neutral Do analysts prefer MIRA or CELZ? MIRA Pharmaceuticals presently has a consensus price target of $14.00, suggesting a potential upside of 677.78%. Given MIRA Pharmaceuticals' stronger consensus rating and higher probable upside, equities analysts clearly believe MIRA Pharmaceuticals is more favorable than Creative Medical Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MIRA Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Creative Medical Technology 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable earnings & valuation, MIRA or CELZ? Creative Medical Technology has higher revenue and earnings than MIRA Pharmaceuticals. MIRA Pharmaceuticals is trading at a lower price-to-earnings ratio than Creative Medical Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMIRA PharmaceuticalsN/AN/A-$7.85M-$0.51-3.53Creative Medical Technology$10K717.43-$5.49M-$3.81-0.73 SummaryCreative Medical Technology beats MIRA Pharmaceuticals on 8 of the 15 factors compared between the two stocks. Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CELZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELZ vs. The Competition Export to ExcelMetricCreative Medical TechnologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.17M$3.04B$5.66B$9.45BDividend YieldN/A2.49%4.01%4.02%P/E Ratio-0.7321.3928.0720.12Price / Sales717.43275.08417.5199.64Price / CashN/A41.6635.9658.29Price / Book0.768.188.555.81Net Income-$5.49M-$55.10M$3.24B$258.18M7 Day Performance10.80%7.63%4.86%3.98%1 Month Performance13.52%21.73%13.00%14.81%1 Year Performance-22.19%6.45%35.57%19.30% Creative Medical Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELZCreative Medical Technology1.0428 of 5 stars$2.77+1.1%N/A-23.9%$7.17M$10K-0.735MIRAMIRA Pharmaceuticals1.8551 of 5 stars$1.66+7.8%$14.00+743.4%-65.1%$26.06MN/A-3.252TPSTTempest Therapeutics1.6433 of 5 stars$6.69-3.0%$30.00+348.4%-74.2%$25.41MN/A-0.3720FBLGFibroBiologics3.4497 of 5 stars$0.70+8.9%$13.00+1,764.9%-86.2%$25.40MN/A-3.3210ALXOALX Oncology3.3005 of 5 stars$0.47-0.5%$3.30+607.4%-92.9%$25.03MN/A-0.1940Gap UpQTTBQ32 Bio2.3996 of 5 stars$2.08+2.5%$12.17+484.9%-92.3%$24.76M$1.16M-0.4239CVKDCadrenal Therapeutics2.208 of 5 stars$12.26-1.9%$32.00+161.0%N/A$24.58MN/A-1.324Positive NewsTENXTenax Therapeutics1.29 of 5 stars$5.95+0.8%$17.50+194.1%+78.6%$24.48MN/A-2.409Gap DownPULMPulmatrixN/A$6.16-6.0%N/A+204.0%$23.91M$1.92M-1.8420NNVCNanoViricides0.4299 of 5 stars$1.46-8.8%N/A-25.1%$23.47MN/A-2.0320BCABBioAtla1.6564 of 5 stars$0.39-1.3%$5.00+1,169.4%-80.4%$23.31M$11M-0.3260 Related Companies and Tools Related Companies MIRA Pharmaceuticals Alternatives Tempest Therapeutics Alternatives FibroBiologics Alternatives ALX Oncology Alternatives Q32 Bio Alternatives Cadrenal Therapeutics Alternatives Tenax Therapeutics Alternatives Pulmatrix Alternatives NanoViricides Alternatives BioAtla Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELZ) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredBitcoin just humbled Jeff BezosBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CELZ Stock Alerts